【佳學(xué)基因檢測(cè)】解密FOS基因評(píng)估分析結(jié)果,如何指導(dǎo)一個(gè)的健康?
基因檢測(cè)的序列名稱:
FOS
人體基因序列變化與疾病表征數(shù)據(jù)庫(kù)中的基因代碼:
2353
人體基因序列數(shù)據(jù)庫(kù)中國(guó)際交流名稱全稱
Fos proto-oncogene, AP-1 transcription factor subunit
中國(guó)數(shù)據(jù)庫(kù)中基因全稱:
Fos原癌基因,AP-1轉(zhuǎn)錄因子亞基
基因檢測(cè)報(bào)告英文版基因簡(jiǎn)介
The Fos gene family consists of 4 members: FOS, FOSB, FOSL1, and FOSL2. These genes encode leucine zipper proteins that can dimerize with proteins of the JUN family, thereby forming the transcription factor complex AP-1. As such, the FOS proteins have been implicated as regulators of cell proliferation, differentiation, and transformation. In some cases, expression of the FOS gene has also been associated with apoptotic cell death. [provided by RefSeq, Jul 2008]
基因突變所影響的基因信息
Fos基因家族由4個(gè)成員組成:FOS,F(xiàn)OSB,F(xiàn)OSL1和FOSL2。這些基因編碼亮氨酸拉鏈蛋白,可以與JUN家族的蛋白二聚化,從而形成轉(zhuǎn)錄因子復(fù)合物AP-1。因此,F(xiàn)OS蛋白已被認(rèn)為是細(xì)胞增殖,分化和轉(zhuǎn)化的調(diào)節(jié)劑。在某些情況下,F(xiàn)OS基因的表達(dá)也與凋亡細(xì)胞死亡有關(guān)。[由RefSeq提供,2008年7月]
國(guó)際國(guó)內(nèi)該堿基基因序列的其他英語(yǔ)文字母簡(jiǎn)稱:
AP-1, C-FOS, p55
基因解碼對(duì)該基因序列在細(xì)胞核中的染色體所給予的編號(hào):
該基因序列位于人類第14號(hào)染色體上。
基因解碼對(duì)基因序列的正確定位
該基因序列在GRCh37版本中的起始位置坐標(biāo)為:75745477;結(jié)束位置坐標(biāo)為:75748937。該基因序列在GRCh38版本中的起始位置坐標(biāo)為:75278778;結(jié)束位置坐標(biāo)為:75282234。正確的基因信息定位是基因檢測(cè)和對(duì)檢測(cè)結(jié)果進(jìn)行正確解讀的關(guān)鍵。
佳學(xué)基因解碼對(duì)該基因的功能分類:國(guó)際版
Transcription factors/Basic domains
基因解碼對(duì)該基因的功能分類:中文版
轉(zhuǎn)錄因子/基本域
結(jié)構(gòu)與功能基因解碼所揭示的該基因在細(xì)胞內(nèi)發(fā)揮作用的場(chǎng)所(國(guó)際版):
Nucleoplasm
結(jié)構(gòu)與功能基因解碼所揭示的該基因發(fā)揮作用的細(xì)胞內(nèi)位置(中文版):
核質(zhì)
該基因序列變化后增加的疾病風(fēng)險(xiǎn)(國(guó)際版):
Depression, psychotic; Osteitis Fibrosa Disseminata; Lipoatrophic Diabetes Mellitus; Severe major depression with psychotic features; Bone Cysts; Trigeminal Neuralgia; Heat Stroke; Growth hormone excess; Skeletal muscle hypertrophy; Acromegaly; Hemorrhage; Large hand; Broad feet; Hyperplasia of supraorbital margins; Hyperplasia of supraorbital ridge; Hypertrophy of supraorbital margins; Hypertrophy of supraorbital ridge; Lipoatrophy; Prominent supraorbital ridges; Acanthosis Nigricans; Abnormal pigmentation; Neurotoxicity Syndromes; Precocious Puberty; Infarction, Middle Cerebral Artery; Advanced bone age; Generalized hirsutism; Anxiety Disorders; Hypertriglyceridemia result; AMYOTROPHIC LATERAL SCLEROSIS 1; Substance Withdrawal Syndrome; nervous system disorder; Insulin Resistance; Liver Failure; Amphetamine-Related Disorders; Class III malocclusion; Hypertrophy of lower jaw; Increased size of mandible; Mandibular hyperplasia; mandibular excess (physical finding); Hyperalgesia; Hyperhidrosis disorder; Increased sweating; Status Epilepticus; Sweating; Reperfusion Injury; Hyperinsulinism; Diabetes Mellitus; Hyperactive behavior; Hypertrophic Cardiomyopathy; Cocaine-Related Disorders; Juvenile arthritis; Endometriosis; Lung Neoplasms; Liver carcinoma; Unipolar Depression; Hepatomegaly; Mental Depression; Major Depressive Disorder; Hypertensive disease; Depressive disorder; Mammary Neoplasms; Epilepsy; Seizures; Dull intelligence; Low intelligence; Mental Retardation; Mental deficiency; Poor school performance; Intellectual Disability; Liver Cirrhosis, Experimental
如果該基因突變后,風(fēng)險(xiǎn)可能增加的疾病類型(中文版):
抑郁、精神?。徊ド⑿岳w維性骨炎;脂肪萎縮性糖尿??;具有精神病特征的嚴(yán)重抑郁癥;骨囊腫;三叉神經(jīng)痛;中暑;生長(zhǎng)激素過(guò)多;骨骼肌肥大;肢端肥大癥;出血;大手;寬腳;眶上緣增生;眶上脊增生;眶上緣肥大;眶上脊肥大;脂肪萎縮;突出的眶上脊;黑棘皮??;色素沉著異常;神經(jīng)毒性綜合征;性早熟;梗塞大腦中動(dòng)脈;骨齡提前;廣泛性多毛癥;焦慮癥;高甘油三酯血癥結(jié)果;肌萎縮側(cè)索硬化 2型;物質(zhì)戒斷綜合癥;神經(jīng)系統(tǒng)紊亂;胰島素抵抗;肝功能衰竭;苯丙胺相關(guān)疾病; III 類咬合不正;下頜肥大;下頜骨增大;下頜骨增生;下頜過(guò)長(zhǎng)(物理發(fā)現(xiàn));痛覺(jué)過(guò)敏;多汗癥;出汗增多;癲癇持續(xù)狀態(tài);出汗;再灌注損傷;高胰島素血癥;糖尿病;多動(dòng)行為;肥厚性心肌病;可卡因相關(guān)疾病;幼年型關(guān)節(jié)炎;子宮內(nèi)膜異位癥;肺腫瘤;肝癌;單極抑郁癥;肝腫大;精神抑郁癥;嚴(yán)重抑郁癥;高血壓?。灰钟舭Y;乳腺腫瘤;癲癇;癲癇發(fā)作;智力遲鈍;智力低下;智力低下;精神缺陷;學(xué)習(xí)成績(jī)差;智力殘疾;肝硬化實(shí)驗(yàn)性
GWAS基因檢測(cè)所建立的與該基因的疾病關(guān)聯(lián)(國(guó)際版):
正在通過(guò)基因解碼技術(shù)進(jìn)行收集、查證并編輯,請(qǐng)關(guān)注佳學(xué)基因,獲得及時(shí)更新的人類基因序列變化與疾病表征數(shù)據(jù)庫(kù)的更新內(nèi)容
GWAS基因檢測(cè)所解碼的該基因突變會(huì)增加風(fēng)險(xiǎn)的疾病種類(中文版):
正在通過(guò)基因解碼技術(shù)進(jìn)行收集、查證并編輯,請(qǐng)關(guān)注佳學(xué)基因,獲得及時(shí)更新的人類基因序列變化與疾病表征數(shù)據(jù)庫(kù)的更新內(nèi)容
以該基因做靶點(diǎn)的藥物(國(guó)際版):
Nadroparin (Transcriptional activator activity, rna polymerase ii core promoter proximal region sequence-specific binding)
針對(duì)該基因所產(chǎn)生的突變,可能有正確效果的藥物(中文版):
那屈肝素(轉(zhuǎn)錄激活劑活性,RNA 聚合酶 ii 核心啟動(dòng)子近端區(qū)域序列特異性結(jié)合)
(責(zé)任編輯:佳學(xué)基因)